Senior Yahoo! Exec Brad Garlinghouse recently wrote a memo to senior management sharing his thoughts on what is wrong with Yahoo! and what he things it will take to fix it.
I don’t know if this was intended or not (I suspect it was), but this so-called “Peanut Butter Manifesto” (his point is that Yahoo! is spreading itself thinly across everything) showed up yesterday in the Wall Stree Journal.
It is worth a read, I guess, though nothing in it comes as a surprise.
More interesting is this bold move by Garlinghouse. I’d put money that he is shortly either going to be running the joint or joining the list of Internet execs out on the street.
6 Comments
Post a commentTrackbacks & Pingbacks
- The Blogging Times » All This Talk Of Peanut Butter Is Giving Me The Munchies
- duke university basketball ticket
VCMike's Blog 
It will be interesting to see what Yahoo does next.
Well, I don’t know if Yahoo can stop playing catch up after letting Google go so far beyond. They are bound to be following for a while unless they do something radical.
From: David Gigolashvili.
General Director.
Company “777” Ltd.
E-mail: davidcom777@gmail.com
Dear, Ladies and Gentlemen!
Our group – Doctor of pharmaceutical Sciences, professor, academician Vajha Eriashvili, Laureate of state premium, doctor of medical sciences, professor Alexander Tsalughelashvili, engineer and economist David Gigolashvili, – The project for biopharmaceutical research anufacturing, reception of liquid and steady medicinal forms, Biopharmaceuticals, The factory will let out (physiological) intravenous solutions IVPC of transfusion and a syringe, the US FDA (GMP) standards in Georgia. We established “777” LTD company, which is registered in Tbilisi, 24th of December 1998 year, 20643846.
With that end in view we carry on negotiations with «S.B.T Technologies.»as they can supply us with technologies, project of equipments and systems that meet the GMP&ISO 9002 standards.
Our Facility’s design is the latest in State-of-the Art manufacturing technology and is built to be more flexible in its production capacities, and to enhance the quality of the environment in which Iv Solutions are produced. Better controlled, cleaner environment, better, safer products!
Production of IVPC is very actual in Georgia. Technological presses offered by European IVPC producers don’t meet the standards of clean environment (class 100) that is required by US FDA standards. Nowadays IVPC production and realization is possible neither in Georgia nor in European and UIS (Union of Independent States) countries.
IVPC demand in US and Canada is 4 L. per inhabitant every year, 3,5 L in Europe, in Georgia according to World Organization of Health is needed no less than 1 L. IPVC.
In this project it is also foreseen preparation of cadres in US according to US FDA (GMP) demands.
IVPC Facility are designed and built to meet the US FDA (GMP) extremely stringent quality standards, which are acceptable worldwide. Therefore, the product manufactured by our Facility can be marked on a global scale.
None of the Facilities built by European companies can offer the same.
As you can see IVPC Facility, no matter what production configuration you choose, offer the highest cost effectiveness (capital outlay per one unit of production capability ratio) and therefore the highest and fastest return on investment.
In general, it is well known fact that the level of medicine practiced in the United States and medical products used in US are superior to most European countries because of the high standards, strict requirements and stringent regulations the US Government through its FDA imposes on medical industry. All these quality are reflected in the products our industry manufactures and offers.
We inform that Government consider the realization of project of IVPC advisable and they are ready to help us. According to above-mentioned the building of IVPC producer Facility that meet the GMP standards is very important and they are ready to discuss and carry on negotiations with investors about financing of this project.
In addition, in parallel on the basis of a factory we plan to create biopharmaceutical research manufacture of reception of liquid and firm medicinal forms.
Since 1980, in Tbilisi, the Republic of Georgia, has been founded the Research Bipharmacy Centre the main purpose of which is to create pharmaceutical preparations utilizing local raw materials.
At the Research Biopharmacy Centre, the Republic of Georgia, a completely novel local raw material has been fond to contain up to 30 – 40mg% of Hyaluronic acid, and the molecular weight is fluctuating approximately from to 7 millions.
The initial hurification and investigation of the material was conducted through sectrophotome try. At the moment, due to the lack of necessary equipment the further purification of our material as its dosage form obtaining and standardization have become impracticable.
Dear Sir, we would like offer you to undertake the purification and standardization of our specimen for which our semiproduct in the liquid or solid (powder) form will be immediately send to you at you request, if any.
We consider it expedient cooperate with you and to start joint production of the Hyaluronic acid in Georgia should you be interested.
Preliminary estimation has shown that about 0,1 kg of Hyaluronic acid and more can be produced in Georgia at the initial stage.
Dear,Ladies and Gentlemen! We hope that you will discuss our project carefully and positively decide to help us in finding financial source for realization of this project.
I hope that our collaboration will be fertile and useful.
Yours respectfully,
David Gigolashvili
General Director
“777” Company
E-mail: dgigolashvili@yahoo.com
E-mail: davidcom777@gmail.com
Классные мультфильмы бесплатно на Кинозоуне.